SS
GBT

Steve Schonfeld’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Steve Schonfeld’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,906
Closed -$508K – 3351
2022
Q2 		$508K Sell
15,906
-25,673
-62% -$752K ﹤0.01% 1354
2022
Q1 		$1.44M Sell
41,579
-51,961
-56% -$1.55M 0.01% 848
2021
Q4 		$2.74M Buy
93,540
+43,067
+85% +$1.33M 0.02% 619
2021
Q3 		$1.29M Buy
50,473
+30,973
+159% +$910K 0.01% 867
2021
Q2 		$683K Buy
+19,500
New +$761K 0.01% 1054
2021
Q1 		– Sell
-47,739
Closed -$2.07M – 2260
2020
Q4 		$2.07M Buy
+47,739
New +$2.35M 0.03% 590
2019
Q3 		– Sell
-128,700
Closed -$6.77M – 1313
2019
Q2 		$6.77M Buy
128,700
+55,700
+76% +$3.2M 0.24% 107
2019
Q1 		$3.86M Buy
+73,000
New +$3.59M 0.13% 206
2018
Q4 		– Sell
-11,400
Closed -$433K – 1284
2018
Q3 		$433K Sell
11,400
-66,100
-85% -$2.93M 0.02% 603
2018
Q2 		$3.5M Buy
+77,500
New +$3.53M 0.19% 183
2018
Q1 		– Sell
-22,350
Closed -$880K – 1034
2017
Q4 		$880K Sell
22,350
-50,541
-69% -$1.89M 0.07% 330
2017
Q3 		$2.26M Buy
+72,891
New +$2.05M 0.21% 141
2016
Q3 		– Sell
-77,912
Closed -$1.29M – 588
2016
Q2 		$1.29M Buy
+77,912
New +$1.57M 0.29% 94

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Steve Schonfeld's GBT Position: Q3 2022 in Review

Steve Schonfeld sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 15,906 shares — an estimated $508K sold.

Steve Schonfeld first reported a position in GBT in Q2 2016 and held it in 13 quarters. The position peaked at $6.77M in Q2 2019. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Steve Schonfeld reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Steve Schonfeld sold 15,906 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $508K.
  • Steve Schonfeld first reported a position in Global Blood Therapeutics, Inc. in Q2 2016 and held it in 13 quarters.
  • Steve Schonfeld's Global Blood Therapeutics, Inc. position peaked at $6.77M in Q2 2019.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.